Am J Nurs. 2023 Feb 1;123(2):62. doi: 10.1097/01.NAJ.0000919764.55911.7b.
According to this study: Mindfulness-based stress reduction is well tolerated and has comparable effectiveness to a first-line medication for people who have anxiety disorders.At least one study-related adverse event occurred in 78.6% of patients in the escitalopram group and in 15.4% of those in the mindfulness-based stress reduction group.
正念减压疗法耐受性良好,对于患有焦虑症的患者,其疗效可与一线药物相媲美。在依地普仑组中,至少有 1 种与研究相关的不良事件发生在 78.6%的患者中,而在正念减压组中,该比例为 15.4%。